Lombardi A, Concepcion E, Hou H, Arib H, et al. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes. J Autoimmun 2020 Sep 17:102543. doi: 10.1016/j.jaut.2020.102543.
PMID: 32951964